Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3556)
Exicure, Inc. (XCUR)
Exicure HiTron Inc. — 10% Owner
Shares
741,272
Price
$4.50
Total Value
$3.34M
Shares Held After
2,592,061
% of Holdings
22.2%
PUMA BIOTECHNOLOGY, INC. (PBYI)
AUERBACH ALAN H — Director
Shares
18,012
Price
$5.88
Total Value
$105.89K
Shares Held After
7,145,951
% of Holdings
0.3%
PUMA BIOTECHNOLOGY, INC. (PBYI)
HUNT DOUGLAS M — The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Shares
5,014
Price
$5.88
Total Value
$29.48K
Shares Held After
155,907
% of Holdings
3.1%
PUMA BIOTECHNOLOGY, INC. (PBYI)
NOUGUES MAXIMO F — Chief Financial Officer
Shares
6,405
Price
$5.88
Total Value
$37.65K
Shares Held After
193,284
% of Holdings
3.2%
CODEXIS, INC. (CDXS)
Lutz Stefan — CSO
Shares
4,685
Price
$1.70
Total Value
$7.95K
Shares Held After
138,775
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$510.00
Total Value
$510.00K
Shares Held After
4,190
% of Holdings
19.3%
GALECTIN THERAPEUTICS INC (GALT)
Jamil Khurram — Chief Medical Officer
Shares
21,446
Price
$3.65
Total Value
$78.20K
Shares Held After
0
% of Holdings
100.0%
GALECTIN THERAPEUTICS INC (GALT)
CALLICUTT JACK W — Chief Financial Officer
Shares
20,354
Price
$3.67
Total Value
$74.70K
Shares Held After
7,614
% of Holdings
72.8%
GALECTIN THERAPEUTICS INC (GALT)
LEWIS JOEL — Director
Shares
37,698
Price
$3.58
Total Value
$134.85K
Shares Held After
832,592
% of Holdings
4.3%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
2,000
Price
$80.00
Total Value
$160.00K
Shares Held After
185,371
% of Holdings
1.1%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
445
Price
$37.75
Total Value
$16.80K
Shares Held After
86,311
% of Holdings
0.5%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
43,168
Price
$7.82
Total Value
$337.57K
Shares Held After
661,041
% of Holdings
6.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
40,761
Price
$0.65
Total Value
$26.49K
Shares Held After
2,413,158
% of Holdings
1.7%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
675
Price
$98.40
Total Value
$66.42K
Shares Held After
278,629
% of Holdings
0.2%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
4,905
Price
$97.33
Total Value
$477.40K
Shares Held After
279,304
% of Holdings
1.7%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
3,963
Price
$96.75
Total Value
$383.42K
Shares Held After
284,209
% of Holdings
1.4%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
225
Price
$98.40
Total Value
$22.14K
Shares Held After
81,733
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,635
Price
$97.33
Total Value
$159.13K
Shares Held After
81,958
% of Holdings
2.0%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
1,321
Price
$96.75
Total Value
$127.81K
Shares Held After
83,593
% of Holdings
1.6%
Nuvalent, Inc. (NUVL)
Turner Christopher Durant — Chief Medical Officer
Shares
225
Price
$98.40
Total Value
$22.14K
Shares Held After
55,130
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Turner Christopher Durant — Chief Medical Officer
Shares
1,635
Price
$97.33
Total Value
$159.13K
Shares Held After
55,355
% of Holdings
2.9%
Nuvalent, Inc. (NUVL)
Turner Christopher Durant — Chief Medical Officer
Shares
1,321
Price
$96.75
Total Value
$127.81K
Shares Held After
56,990
% of Holdings
2.3%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
183
Price
$98.40
Total Value
$18.01K
Shares Held After
42,134
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,331
Price
$97.33
Total Value
$129.55K
Shares Held After
42,317
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
1,075
Price
$96.75
Total Value
$104.01K
Shares Held After
43,648
% of Holdings
2.4%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
225
Price
$98.40
Total Value
$22.14K
Shares Held After
40,617
% of Holdings
0.6%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,635
Price
$97.33
Total Value
$159.13K
Shares Held After
40,842
% of Holdings
3.8%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
1,321
Price
$96.75
Total Value
$127.81K
Shares Held After
42,477
% of Holdings
3.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
189
Price
$98.40
Total Value
$18.60K
Shares Held After
65,888
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,369
Price
$97.33
Total Value
$133.24K
Shares Held After
66,077
% of Holdings
2.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,106
Price
$96.75
Total Value
$107.01K
Shares Held After
67,446
% of Holdings
1.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
3,111
Price
$6.04
Total Value
$18.79K
Shares Held After
757,500
% of Holdings
0.4%
PharmaCyte Biotech, Inc. (PMCB)
SCHECHTER JONATHAN — Director
Shares
20,000
Price
$0.79
Total Value
$15.81K
Shares Held After
172,500
% of Holdings
11.6%
PharmaCyte Biotech, Inc. (PMCB)
Silverman Joshua — Director
Shares
30,000
Price
$0.79
Total Value
$23.67K
Shares Held After
376,250
% of Holdings
8.0%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
29,450
Price
$172.33
Total Value
$5.08M
Shares Held After
7,229
% of Holdings
80.3%
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
6,931
Price
$1.01
Total Value
$7.01K
Shares Held After
152,499
% of Holdings
4.3%
AN2 Therapeutics, Inc. (ANTX)
Chanda Sanjay — Chief Development Officer
Shares
5,956
Price
$1.01
Total Value
$6.03K
Shares Held After
75,823
% of Holdings
7.3%
AN2 Therapeutics, Inc. (ANTX)
Prior Stephen David — Chief Strategy Officer
Shares
2,858
Price
$1.01
Total Value
$2.89K
Shares Held After
59,086
% of Holdings
4.6%
AN2 Therapeutics, Inc. (ANTX)
Day Lucy — Chief Financial Officer
Shares
5,512
Price
$1.01
Total Value
$5.58K
Shares Held After
75,363
% of Holdings
6.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
3,618
Price
$1.97
Total Value
$7.11K
Shares Held After
128,499
% of Holdings
2.7%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
3,801
Price
$1.97
Total Value
$7.48K
Shares Held After
146,229
% of Holdings
2.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
7,097
Price
$1.97
Total Value
$13.96K
Shares Held After
150,030
% of Holdings
4.5%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
5,102
Price
$1.97
Total Value
$10.03K
Shares Held After
657,737
% of Holdings
0.8%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
6,834
Price
$1.97
Total Value
$13.44K
Shares Held After
159,464
% of Holdings
4.1%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
5,100
Price
$1.97
Total Value
$10.03K
Shares Held After
222,644
% of Holdings
2.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
WAGNER CHARLES F JR — EVP, CO & FO
Shares
9,532
Price
$461.00
Total Value
$4.39M
Shares Held After
37,725
% of Holdings
20.2%
Maze Therapeutics, Inc. (MAZE)
Sohn Catherine A. — Director
Shares
2,493
Price
$38.62
Total Value
$96.27K
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
Kutzkey Tim — Director
Shares
8,003
Price
$19.89
Total Value
$159.16K
Shares Held After
989,893
% of Holdings
0.8%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
54
Price
$76.95
Total Value
$4.16K
Shares Held After
6,902
% of Holdings
0.8%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
1,615
Price
$173.33
Total Value
$279.93K
Shares Held After
93,139
% of Holdings
1.7%
Showing 3201–3250 of 3556 transactions (page 65 of 72)